Optimization of enantioselective synthesis of methyl (R)-2-chloromandelate by whole cells of Saccharomyces cerevisiae

Biotechnology Letters

Volumn 32, Issue 10, 2010, Pages 1529-1531

  Jeong, Min ^a   Lee, Yoon Mi ^b   Hong, Soon Ho ^a   Park, Sung Young ^c   Yoo, Ik keun ^a   Han, Mee Jung ^d  

^a University of Ulsan   (South Korea)

^b Ulsan Fine Chemical Industry Center   (South Korea)

^c Chungju National University   (South Korea)

^d Dongyang University   (South Korea)

Author keywords

Asymmetric reduction; Biotransformation; Methyl (R) 2 chloromandelate; Saccharomyces cerevisiae

Indexed keywords

ASYMMETRIC REDUCTION; BIOTRANSFORMATION; CLOPIDOGREL; ENANTIOMERIC EXCESS; ENANTIOSELECTIVE SYNTHESIS; METHYL (R)-2-CHLOROMANDELATE; SACCHAROMYCES CEREVISIAE; WHOLE CELL;

YEAST;

GLUCOSE; MANDELIC ACID DERIVATIVE; METHYL 2 CHLOROBENOZYLFORMATE; METHYL 2 CHLOROMANDELATE; METHYL 2-CHLOROBENOZYLFORMATE; METHYL 2-CHLOROMANDELATE; PHENYLACETIC ACID DERIVATIVE;

ARTICLE; BIOTRANSFORMATION; CHEMISTRY; GENETICS; METABOLISM; PH; SACCHAROMYCES CEREVISIAE; STEREOISOMERISM;

BIOTRANSFORMATION; GLUCOSE; HYDROGEN-ION CONCENTRATION; MANDELIC ACIDS; PHENYLACETATES; SACCHAROMYCES CEREVISIAE; STEREOISOMERISM;

SACCHAROMYCES CEREVISIAE;

EID: 77956775211     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-010-0396-4     Document Type: Article

References (11)

1. de Souza Pereira R (1998) The use of baker's yeast in the generation of asymmetric centers to produce chiral drugs and other compounds. Crit Rev Biotechnol 18: 25-83.
2. Ema T, Ide S, Okita N, Sakai T (2008) Highly efficient chemoenzymatic synthesis of methyl (R)-o-chloromandelate, a key intermediate for clopidogrel, via asymmetric reduction with recombinant Escherichia coli. Adv Synth Catal 350: 2039-2044.
3. Glieder A, Weis R, Skranc W, Poechlauer P, Dreveny I, Majer S, Wubbolts M, Schwab H, Gruber K (2003) Comprehensive step-by-step engineering of an (R)-hydroxynitrile lyase for large-scale asymmetric synthesis. Angew Chem Int Ed 42: 4815-4818.
4. Johanson T, Carlquist M, Olsson C, Rudolf A, Frejd T, Gorwa-Grauslund MF (2008) Reaction and strain engineering for improved stereo-selective whole-cell reduction of a bicyclic diketone. Appl Microbiol Biotechnol 77: 1111-1118.
5. Katz M, Sarvary I, Frejd T, Hahn-Hägerdal B, Gorwa-Grauslund MF (2002) An improved stereoselective reduction of a bicyclic diketone by Saccharomyces cerevisiae combining process optimization and strain engineering. Appl Microbiol Biotechnol 59: 641-648.
6. Li G, Huang K, Jiang Y, Ding P (2007) Production of (R)-mandelic acid by immobilized cells of Saccharomyces cerevisiae on chitosan carrier. Process Biochem 42: 1465-1469.
7. Patel RN (2006) Biocatalysis: synthesis of chiral intermediates for drugs. Curr Opin Drug Discov Dev 9: 741-764.
8. Schmid A, Dordick JS, Kiener A, Wubbolts M, Witholt B (2001) Industrial biocatalysis today and tomorrow. Nature 409: 258-268.
9. 2O as additive. Org Lett 7: 5425-5427.
10. Uhm K, Lee S, Kim H, Kang H, Lee Y (2007) Enantioselective resolution of methyl 2-chloromandelate by Candida antarctica lipase A in a solvent-free transesterification reaction. J Mol Catal B 45: 34-38.
11. van Langen LM, Selassa RP, van Rantwijk F, Sheldon RA (2005) Cross-linked aggregates of (R)-oxynitrilase: a stable, recyclable biocatalyst for enantioselective hydrocyanation. Org Lett 7: 327-329.